| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥20.68B | +61.6% |
| Gross profit | ¥2.90B | — |
| Operating income | ¥1.59B | — |
| Net income | ¥1.44B | +23.9% |
| Gross margin | 14.0% | Net margin 7.0% |
| Revenue Q/Q | +25.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥17.78B | 86.0% |
| R&D | ¥0.84B | 4.1% |
| SG&A | ¥0.77B | 3.7% |
| Tax & other | ¥0.15B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
爱尔眼科 ・ 同花顺 ・ 东方财富 ・ 智飞生物 ・ 汇川技术 ・ 光线传媒 ・ 阳光电源 ・ 中际旭创 ・ 晶盛机电 ・ 天孚通信 ・ 三环集团 ・ 芒果超媒
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies